Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Compare brokers on index fund selections, focusing on fund variety, fees, and ease of use to pick the best platform for your needs.
27,890 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
The White House confirms a policy review of a temporary Jones Act waiver as oil nears $100 a barrel and fuel costs ri...
Jane Street resumes bitcoin activity as probes and lawsuits loom. In the latest window, 25.36 BTC, worth $15.08 milli...
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
Bond markets show renewed stress, with yields rising and liquidity thinning. Analysts say a familiar pattern is reeme...
Gas prices hover near a critical threshold as policymakers push a mix of measures aimed at stabilizing energy costs. ...
Nasdaq and Talos unveil an industry-scale integration aimed at freeing $35 billion in trapped collateral, linking ris...
Asia is turning to U.S. LNG suppliers as disruptions in the Middle East squeeze global gas flows. The response is swi...
Washington moves to outlaw noncompete agreements statewide, imposing a 2027 deadline. The sweeping policy reshapes hi...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
Discover how Hudson Pacific Properties is shaping its 2026 path after Q1 results. This guide breaks down earnings sig...
A drone strike lit a cargo ship off Qatar, testing a fragile Iran ceasefire. UAE and Kuwait reported drone incursions...